Biomonitoring great,but do it the right way!

Abstract

Get full access to this article

View all access options for this article.

References

Poupeau

Tanguay

Plante

et al.

Pilot study of biological monitoring of four antineoplastic drugs among Canadian healthcare workers. J Oncol Pharm Pract 2017; 23: 323–332.

Hirst

Tse

Mills

et al.

Occupational exposure to cyclophosphamide. Lancet 1984; 1: 186–188.

Sessink

PJM

Van de Kerkhof

MCA

Anzion

RBM

et al.

Environmental contamination and assessment of exposure to antineoplastic agents by determination of cyclophosphamide in urine of exposed pharmacy technicians: is skin absorption an important exposure route?

Arch Environ Health 1994; 49: 165–169.

Fransman

Vermeulen

Kromhout

. Dermal exposure to cyclophosphamide in hospitals during preparation, nursing and cleaning activities. Int Arch Occup Environ Health 2005; 78: 403–412.

Maeda

Miyawaki

Matsumoto

et al.

Evaluation of environmental contaminations and occupational exposures involved in preparation of chemotherapeutic drugs. Yakugaku Zasshi 2010; 130: 903–910.

Sottani

Porro

Imbriani

et al.

Occupational exposure to antineoplastic drugs in four Italian health care settings. Toxicol Lett 2012; 213: 107–115.

Ziegler

Mason

Baxter

. Occupational exposure to cytotoxic drugs in two UK oncology wards. Occup Environ Med 2002; 59: 608–612.

Turci

Minoia

Sottani

et al.

Occupational exposure to antineoplastic drugs in seven Italian hospitals: the effect of quality assurance and adherence to guidelines. J Oncol Pharm Pract 2011; 17: 320–332.

Wick

Slawson

Jorgenson

et al.

Using a closed-system protective device to reduce personnel exposure to antineoplastic agents. Am J Health Syst Pharm 2003; 60: 2314–2320.

10.

Tanimura

Yamada

Sugiura Shin-ichi et al.

An environmental and biological study of occupational exposure to cyclophosphamide in the pharmacy of a Japanese community hospital designated for the treatment of cancer. J Health Sci 2009; 55: 750–756.

11.

Yoshida

Tei

Mochizuki

et al.

Use of a closed system device to reduce occupational contamination and exposure to antineoplastic drugs in the hospital work environment. Ann Occup Hyg 2009; 53: 153–160.

12.

Sugiura

Nakaishi

Asano

et al.

Multicenter study for environmental and biological monitoring of occupational exposure to cyclophosphamide in Japan. J Oncol Pharm Pract 2010; 17: 20–28.

13.

Hon

Teschke

Shen

et al.

Antineoplastic drug contamination in the urine of Canadian healthcare workers. Int Arch Occup Environ Health 2015; 88: 933–941.

14.

Ramphal

Bains

Vaillancourt

et al.

Occupational exposure to cyclophosphamide in nurses at a single center. J Occup Environ Med 2014; 56: 304–312.